How peptides are regulated in New Zealand

If you search for whether peptides are legal in New Zealand, most of what comes back is written by people selling them. This page is not. It describes how the regulatory system actually classifies these products, using the regulators’ own published guidance.

“Peptide” is not a legal category

There is no line in New Zealand law that says peptides are legal or illegal. A peptide is just a short chain of amino acids — insulin is a peptide, so is collagen in your food. The law does not ask what molecular class something belongs to. It asks what the product is for.

Medsafe categorises a product on three things: its ingredients, its purpose for use, and the manner in which it is presented in the market. If a product has a therapeutic purpose, the Medicines Act 1981 applies to it and it is a medicine — whatever the seller calls it.

Therapeutic purpose is defined broadly. It covers preventing, diagnosing, treating or curing a disease, and it also covers influencing, inhibiting or modifying a physiological process. That second limb is the one that catches most peptide marketing. A product sold to accelerate healing, alter body composition or change how a physiological system behaves is being sold for a therapeutic purpose, even if the word “treatment” never appears.

The presentation test is where most sites fail

This is the part that surprises people. Medsafe’s guidance is explicit that a product’s purpose for use “may be stated or implied” in any of the following:

• product label statements and claims
• websites
• advertising depictions
• testimonials
• references to traditional use
• social media posts
• expected use

So a vial sold as a “research chemical, not for human consumption” is not neutralised by that disclaimer if the website around it, the reviews on it, or the seller’s social media describe what it does to a body. The disclaimer is not the presentation. Everything around the product is.

This is why the “research use only” framing is far weaker protection than the people relying on it appear to believe.

What follows from being a medicine

Once something is a medicine, two things kick in.

Consent to distribute. Medicines need to be evaluated and consented before they can be distributed in New Zealand. Products without that consent are unapproved medicines. There are narrow legal routes by which a doctor can obtain an unapproved medicine for a particular patient, but those are clinician-initiated pathways, not a consumer purchasing channel.

No advertising. Unapproved medicines supplied under exemption provisions cannot be advertised. Medsafe’s guidance treats this broadly: publishing availability in any medium is advertising, so is personal representation by a product representative, so are unsolicited price lists — and so is using influencers or testimonials. The Advertising Standards Authority’s Therapeutic and Health Advertising Code states the same principle from the other direction: only medicines evaluated by Medsafe and holding consent to distribute may be advertised in New Zealand. The Code also prohibits patient testimonials in direct-to-consumer advertising of prescription medicines outright.

Where dietary supplements sit

Products genuinely sold as dietary supplements or supplemented foods are in a different category — but they buy that position by staying out of therapeutic territory. Therapeutic claims are prohibited for dietary supplements, supplemented foods and cosmetics; making one reclassifies the product as a medicine. Health products may make health support claims — statements about normal physiological function or nutritional support — where those are properly substantiated. The gap between “supports normal muscle function” and “repairs injured tissue” is not a stylistic difference. It is the boundary between two regulatory regimes.

What this means if you are reading about peptides

Three practical consequences.

If a New Zealand-facing site is describing peptide effects on the body and offering the product, it is very likely operating outside these rules. That is information about the seller, not an endorsement of the product.

Testimonials and before-and-after content are not weak evidence that happens to be popular. In this category they are a regulatory tripwire, which is part of why serious sources do not publish them.

And the individuals with a legitimate route to a peptide-based medicine got there through a prescriber who assessed them. That is a conversation with a doctor or pharmacist, not a purchase decision.

What this page deliberately does not do

It does not tell you whether any specific peptide works, what to take, how much, or where to get it. It has no view on whether the current rules are well drawn. It describes what the published regulatory guidance says, links to it, and stops there.